Cargando…
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is a highly refractory cancer associated with increasing mortality, which currently lacks effective treatment options. Interleukin-24 (IL-24) is a novel tumor suppressor cytokine that can selectively induce cancer cell apoptosis, and it has been utilized as...
Autores principales: | Deng, Lili, Yang, Xue, Ding, Yuedi, Fan, Jun, Peng, Ying, Xu, Dong, Huang, Biao, Hu, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922813/ https://www.ncbi.nlm.nih.gov/pubmed/35292065 http://dx.doi.org/10.1186/s12985-022-01779-1 |
Ejemplares similares
-
An Oncolytic Vaccinia Virus Armed with GM-CSF and IL-24 Double Genes for Cancer Targeted Therapy
por: Deng, Lili, et al.
Publicado: (2020) -
IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer
por: Deng, Lili, et al.
Publicado: (2021) -
Target Therapy With Vaccinia Virus Harboring IL-24 For Human Breast Cancer
por: Deng, Lili, et al.
Publicado: (2020) -
Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
por: Deng, Lili, et al.
Publicado: (2017) -
Evaluation of Tumor Specificity and Immunity of Thymidine Kinase-Deleted Vaccinia Virus Guang9 Strain
por: Ding, Yuedi, et al.
Publicado: (2020)